We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+11.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$37.8B
AUM Growth
+$2.98B
Cap. Flow
-$573M
Cap. Flow %
-1.52%
Top 10 Hldgs %
13.69%
Holding
777
New
103
Increased
269
Reduced
203
Closed
104

Sector Composition

Rank Sector Weight
1 Healthcare 14.96%
2 Industrials 11.65%
3 Financials 11.1%
4 Technology 10.77%
5 Consumer Staples 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUB
651
DELISTED
Cubic Corporation
CUB
$739K ﹤0.01%
14,036
-3,764
-21% -$199K
BSFT
652
DELISTED
BroadSoft, Inc.
BSFT
$683K ﹤0.01%
25,000
-35,000
-58% -$1.04M
XPRO icon
653
Expro Ltd
XPRO
$1.79B
$674K ﹤0.01%
4,161
-57,506
-93% -$9.74M
PNC.WS
654
DELISTED
PNC Financial Services Group Inc
PNC.WS
$673K ﹤0.01%
+37,900
New +$643K
THS
655
DELISTED
Treehouse Foods
THS
$464K ﹤0.01%
6,737
JAH
656
DELISTED
JARDEN CORPORATION
JAH
$451K ﹤0.01%
11,025
NMIH icon
657
NMI Holdings
NMIH
$3.37B
$382K ﹤0.01%
+30,000
New +$399K
SIRI icon
658
SiriusXM
SIRI
$9.97B
$364K ﹤0.01%
10,421
-500,000
-98% -$18.7M
PSTV icon
659
Plus Therapeutics
PSTV
$26.6M
0
ENOV icon
660
Enovis
ENOV
$1.68B
$294K ﹤0.01%
+2,681
New +$268K
RDEN
661
DELISTED
ELIZABETH ARDEN INC
RDEN
$282K ﹤0.01%
7,941
GCVRZ
662
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$209K ﹤0.01%
614,455
-790,000
-56% -$955K
ETRM
663
DELISTED
EnteroMedics Inc.
ETRM
$206K ﹤0.01%
+96
New +$155K
VIRX
664
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$178K ﹤0.01%
+179
New +$185K
AEE icon
665
Ameren
AEE
$30.3B
-363,087
Closed -$12.7M
AES icon
666
AES
AES
$10.5B
-927,000
Closed -$12.3M
AGIO icon
667
Agios Pharmaceuticals
AGIO
$1.79B
-32,500
Closed -$909K
ALSN icon
668
Allison Transmission
ALSN
$9.5B
-3,069,900
Closed -$76.9M
AMCX icon
669
AMC Global Media
AMCX
$492M
-235,050
Closed -$16.1M
AMWD
670
DELISTED
American Woodmark
AMWD
-202,781
Closed -$7.03M
ANF icon
671
Abercrombie & Fitch
ANF
$4.42B
-115,200
Closed -$4.08M
ANSS
672
DELISTED
Ansys
ANSS
-50,000
Closed -$4.33M
APA icon
673
APA Corp
APA
$13.2B
-220,610
Closed -$18.8M
AVGO icon
674
Broadcom
AVGO
$1.85T
-4,771,000
Closed -$20.6M
AZN icon
675
AstraZeneca
AZN
$263B
-400,000
Closed -$20.8M

Similar funds

Adage Capital Partners's Q4 2013 Portfolio in Review

As of Q4 2013, Adage Capital Partners held 777 positions worth $37.8B, up 8.6% from $34.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Adage Capital Partners's Q4 2013 filing shows 103 new, 269 increased, 203 reduced and 104 closed positions. Its largest new stake was Meta Platforms (Facebook): 2,825,000 shares worth $154M. The largest sale was ONYX PHARMACEUTICALS INC, an estimated $512M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.

  • Adage Capital Partners's largest Q4 2013 buy was Meta Platforms (Facebook): 2,825,000 shares worth $154M.
  • Adage Capital Partners added most to SAFEWAY INC in Q4 2013, an estimated $125M increase.
  • Adage Capital Partners's biggest Q4 2013 reduction was PVH, cutting an estimated $198M.
  • Adage Capital Partners fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $512M.
  • Adage Capital Partners's ten largest holdings make up 14% of its $37.8B portfolio in Q4 2013.
  • Adage Capital Partners opened 103 new positions and closed 104 in Q4 2013.
  • Adage Capital Partners's portfolio value rose 8.6% quarter-over-quarter to $37.8B.

Based on Adage Capital Partners's 13F filing for Q4 2013, filed 14 Feb 2014.